Latest Litigation Risk News

Page 3 of 3
Mayne Pharma Group has proposed a $7.40 per share acquisition by Cosette Pharmaceuticals, with unanimous board support and a fair and reasonable opinion from an independent expert. Shareholders will vote on the scheme on June 18, 2025.
Ada Torres
Ada Torres
15 May 2025
Fletcher Building reported a challenging HY25 with a 7% revenue decline and a net loss of NZ$134 million, while executing a $700 million equity raise to strengthen its balance sheet and advancing significant cost reduction initiatives.
Victor Sage
Victor Sage
19 Feb 2025
Smart Parking Limited has reported robust H1 FY25 results, underpinned by a strategic acquisition of Peak Parking LP and a fully underwritten $45 million equity raise to fund its US expansion.
Sophie Babbage
Sophie Babbage
17 Feb 2025
Energy Transition Minerals Ltd has issued a prospectus offering up to 68.75 million free-attaching quoted options to placement participants as part of a $9.35 million capital raising. The options, exercisable at $0.12 and expiring in 18 months, aim to support expansion in Greenland and project development despite ongoing litigation risks.
Maxwell Dee
Maxwell Dee
24 Jan 2025